As Figure 10 showed, IKKε suppression did not sensitize breast cancer cells to cisplatin (10 to 100 μM) (Figure 10a, b) and doxorubicin (0.1 to 10 μM) (Figure 10c, d). This evidence concerns the gene IKBKE and breast cancer.